10 Recruiting Non-small Cell Lung Cancer (NSCLC) Phase 2 Clinical Trials
Active phase 2 studies for non-small cell lung cancer (nsclc) enrolling across the USA. Verify eligibility and contact site coordinators.
All Non-small Cell Lung Cancer (NSCLC) studiesPhase 2 Studies for Non-small Cell Lung Cancer (NSCLC)
🔵 Active, Not Recruiting Phase2
PCSK9 Inhibitor and PD-1 Inhibitor in Patients With Metastatic, Refractory To Prior Anti PD-1 Non-small Cell Lung
📍 Moffitt Cancer Center — Tampa, Florida
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Study of Osimertinib and Stereotactic Ablative Radiation (SABR) in EGFR Mutant NSCLC
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2
Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE)
📍 University of Birmingham Alabama — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2
Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
📍 Henry Ford Health — Detroit, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
📍 City of Hope — Duarte, California
View Study & Checklist ➔ 🟢 Recruiting Phase2
Pembrolizumab for Advanced NSCLC and PS 2-3
📍 Mount Sinai Hospital — New York, New York
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
📍 UC Irvine/Chao Family Comprehensive Cancer Center — Orange, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
View Study & Checklist ➔ 🟢 Recruiting Phase2
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
📍 Compassionate Cancer Care Center — Fountain Valley, California
View Study & Checklist ➔ 🟢 Recruiting Phase1 / Phase2
Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs
📍 Sarah Cannon Research Institute (SCRI) (The SCRI Oncology Research Consortium) — Nashville, Tennessee
View Study & Checklist ➔